<DOC>
	<DOC>NCT03060954</DOC>
	<brief_summary>Interventional, Multicentre, controlled, randomized, single blind, twoarmed non-inferiority trial</brief_summary>
	<brief_title>Non-Inferiority Study Comparing MINI WELL READY 速 and FineVision 速 in Patients With Cataract Surgery</brief_title>
	<detailed_description>To evaluate the non-inferiority of the progressive extended depth of focus Intraocular Lens MINI WELL READY速 in terms of visual performance, quality of vision and subjective outcomes versus the trifocal Intraocular Lens FineVision速 after a follow up period of 2-6 months.</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Vision Disorders</mesh_term>
	<criteria>Bilateral cataract surgery required, no other ocular comorbidities Healthy corneas, not treated surgically Available for secondeye surgery within 1 week of the initial operation Spherical refraction between 8.00D and +6.00D Willing to adhere to the study visit schedule Normal anterior and posterior segments Clear intraocular media other than cataract Written informed consent consistent with local regulation research in human subjects Any previous history of ocular trauma or prior ocular surgery (including previous cataract surgery and s) Ocular comorbidities determining potential postoperative Visual Acuity less than 0.50 decimal (0.3 logMAR) Expected to require retinal laser treatment Psudoexfoliation Abnormal pupil size and position Pupil size &gt; 7 mm under mesopic condition Use of contact lenses 30 days before the preoperative visit Corneal warpage (e.g. Keratoconus, Pellucid Marginal Corneal Degeneration or Keratoglobus) Corneal astigmatism greater than 0.75D Active ocular disease in the operative eye, for example, chronic uveitis, proliferative diabetic retinopathy, chronic glaucoma unresponsive to medication, corneal decompensation and corneal endothelial cell insufficiency (such as Fuch's endothelial dystrophy) Subjects with any systemic disease that could increase operative risk or confound the outcome Pregnant or lactating or planning a pregnancy at the time of enrolment Subjects participating in a concurrent clinical trial or if they have participated in an ophthalmology clinical trial within the last 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Visual Disorder</keyword>
</DOC>